Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Withdrawn

• Conditions: Fallopian Tube Carcinoma; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Carcinoma; Primary Peritoneal Carcinoma

• Registration Number: NCT01445275
• Lead Sponsor: Gynecologic Oncology Group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-9-30
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Female
• Target Recruitment: 0

Inclusion Criteria

Inclusion Criteria:<br><br> - Women who were eligible and evaluable for GOG-0199, a prospective, non-randomized,<br> natural history study<br><br> - Data collected from GOG-0199 available

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cost-effectiveness of RRSO versus OCS